THIRD AMENDMENT TO THE EXCLUSIVE LICENSE AGREEMENT RENEWALTheexclusive License Agreement • April 14th, 2022 • Quoin Pharmaceuticals, Ltd. • Surgical & medical instruments & apparatus
THIS AMENDMENT TO THE EXCLUSIVE LICENSE AGREMEMENT RENEWAL (this “Amendment”) is made and entered into as of January 27, 2021, by and among Skinvisible, Inc., a Nevada corporation (referred to as “SKINVISIBLE” ), and Quoin Pharmaceuticals, Inc., a Delaware corporation (“Licensee”).
FOURTH AMENDMENT TO THE EXCLUSIVE LICENSE AGREEMENT RENEWALTheexclusive License Agreement • April 14th, 2022 • Quoin Pharmaceuticals, Ltd. • Surgical & medical instruments & apparatus
THIS AMENDMENT TO THE EXCLUSIVE LICENSE AGREMEMENT RENEWAL (this “Amendment”) is made and entered into as of April 19, 2021, by and among Skinvisible Pharmaceuticals, Inc., a Nevada corporation (referred to as “SKINVISIBLE” ), and Quoin Pharmaceuticals, Inc., a Delaware corporation (“Licensee”).
